Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science Series: Advancing Gene Therapy, Tools for Developing Your Candidate Therapy.  New gene editing technologies have energized the science of drug discovery and sparked a wave of startups. With the advent of CRISPR/Cas9 systems, a researcher can find an active nuclease on virtually any region of the genome, greatly reducing the time needed to develop novel therapies to treat a wide range of diseases.  But increased choice can lead to problems in building a cell line model yielding the best results. In this presentation, panelists will address common real-world challenges in cell line engineering and explore methods to avoid the pitfalls.